Key result
TEVAR cuts 30-day mortality and complications vs OSR but increases mid-to-long-term re-intervention rates.
Why the study?
The long-term mortality and re-intervention rates of thoracic endovascular aortic repair compared to open surgical repair for thoracic aortic aneurysm are unclear.
Does TEVAR improve early mortality, long-term survival, and re-intervention rates compared to open surgical repair in patients with thoracic aortic aneurysm?
Meta-Analysis
Does TEVAR improve early mortality, long-term survival, and re-intervention rates compared to open surgical repair in patients with thoracic aortic aneurysm?
TEVAR provides superior early clinical outcomes compared to open surgical repair for thoracic aortic aneurysms, but is associated with a higher risk of mid-to-long-term re-intervention.
Answers are grounded in this paper and cite their sources.
TEVAR linked to higher long-term mortality than OSR for descending thoracic aneurysms; randomized trials needed to confirm.
INTRODUCTION: Since the approval, the thoracic endovascular aortic repair (TEVAR) is widely used for the repair of thoracic aortic aneurysm. However, the long-term mortality and re-intervention rates compared to open surgical repair (OSR) are unclear. We aimed to compare the effectiveness of TEVAR with OSR specifically for thoracic aortic aneurysms. EVIDENCE ACQUISITION: We conducted a comprehensive search in MEDLINE, PubMed, EMBASE, CINAHL, PROSPERO, Centre for Reviews and Dissemination, and the Cochrane Library up to November 2020. The main outcomes were early mortality, mid-to-long-term survival, and re-intervention. The quality of the evidence was assessed using the GRADE methodology. All analyses were performed using RevMan with the random effect model and Comprehensive Meta-Analysis software. EVIDENCE SYNTHESIS: One systematic review and 15 individual studies were included. Pooled analysis showed that 30-day mortality, stroke, renal failure, and pulmonary complications were significantly lower in TEVAR versus open surgery. The pooled rate of re-intervention significantly favored the OSR. The long-term survival and mortality favored TEVAR and OSR in one and two studies, respectively, but was non-significant in seven analyzes. CONCLUSIONS: Early clinical outcomes including the 30-day mortality, stroke, renal failure, and pulmonary complications significantly favored the TEVAR. However, the mid-to-long-term re-intervention rate favored the OSR and long-term survival was inconsistent among the studies. The quality of evidence was very low. More studies with longer follow-ups are needed. The use of TEVAR should be decided by taking into account other factors including patient characteristics and preferences, cost, and surgeon expertise.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted a meta-analysis in Thoracic aortic aneurysm. Thoracic endovascular aortic repair (TEVAR) vs. Open surgical repair (OSR) was evaluated on Early mortality, mid-to-long-term survival, and re-intervention. Thoracic endovascular aortic repair significantly reduced 30-day mortality and complications compared to open surgical repair, but had a higher mid-to-long-term re-intervention rate.
Synapse has enriched 10 related papers. Consider them for comparative context: